DataMEDS AI, Inc.
Research DataMEDS AI, Inc. (MEDS) on Bullrun: market cap USD 7.46M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMEDS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Market capUSD 7.46M
- Financial periodQ2 2026
- RevenueUSD 1.78M
- Net income-USD 18.36M
- Free cash flow-USD 3.14M
- Gross margin10.2%
Valuation Snapshot
latest market cap is USD 7.46M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 23.34M | -USD 101.27M | -USD 11.74M | -27.5% | -71.5 | USD 42.57K | USD 24.77M | -USD 12.45M |
| FY2024 | USD 18.13M | -USD 6.86M | -USD 1.60M | 9.7% | -7.5 | USD 1.03M | USD 25.11M | USD 6.73M |
| FY2023 | USD 0 | -USD 2.90M | -USD 349.14K | n/a | -3 | USD 1.36K | USD 350.00K | -USD 2.90M |
| FY2022 | USD 32.78M | -USD 2.74M | USD 0 | 17.5% | -2.9 | USD 0 | USD 1.58M | -USD 5.25K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 7.46M | n/a | n/a | n/a |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2024 | 9.5 USD |
About DataMEDS AI, Inc.
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DataMEDS AI, Inc.'s market cap?
DataMEDS AI, Inc.'s market capitalization is USD 7.46M.
What does DataMEDS AI, Inc. do?
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services.